logo

C4 Therapeutics Inc (CCCC) Stock: The Story of a 52-Week Stock Range

TOST Stock

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. C4 Therapeutics Inc’s current trading price is -45.54% away from its 52-week high, while its distance from the 52-week low is 510.38%. The stock’s price range during this period has varied between $1.06 and $11.88. The company, active in the Healthcare sector, saw a trading volume of around 1.04 million for the day, considerably lower average daily volume of 2.64 million observed over the last three months.

C4 Therapeutics Inc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $11.88 on 03/04/24, while the lowest price during the same period was $1.06 on 12/06/23.

How Financial Performance Impacts Market Capitalization

C4 Therapeutics Inc (CCCC) has experienced a quarterly rise of 16.58% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 443.84M and boasts a workforce of 145 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 6.78, with a change in price of +4.96. Similarly, C4 Therapeutics Inc recorded 10,485,571 in trading volume during the last 100 days, posting a change of +328.48%.

How CCCC’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CCCC stands at 0.29. Similarly, the long-term debt-to-equity ratio is also 0.27.

CCCC Stock Stochastic Average

As of today, the raw stochastic average of C4 Therapeutics Inc over the last 50 days is at 2.35%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 0.55%. Further, the company’s Stochastic %K and %D values for the last 20 days were 11.79% and 12.83%, respectively.

CCCC Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 14.51%. However, over the past six months, we’ve seen a weaker performance of 320.13%. The price of CCCC leaped by -21.19% over the last 30 days. And in the last five days, it has fallen by -5.82%.